Vista Pharmaceuticals Ltd (524711) — Board Meeting | 12 September 2026

· BSE 🟡 Notable Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
Resignation of Company Secretary and Compliance Officer effective September 4, 2026
💡 Investor Takeaway
The departure of the Company Secretary may introduce transitional risks but does not directly impact core financial performance or growth prospects.

Vista Pharmaceuticals announced the resignation of Company Secretary and Key Managerial Personnel Mrs. Barkha Jain effective September 4, 2026, to pursue an alternate career outside the organization. The Board accepted her resignation and expressed appreciation for her services. The filing complies with SEBI LODR Regulation 30 requirements and includes necessary disclosures to the stock exchanges.

📄 View Original Announcement (PDF)

About Vista Pharmaceuticals Ltd (524711)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹35.39 Cr ROE: -25.9% ROCE: -27.9%

View full 524711 stock details →

📡 Get AI alerts when 524711 files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track 524711 — Free

📊 More 524711 filings

No other filings yet.

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts for your stocks — summarized by AI daily

Set up your AI Radar — pick stocks, get daily email summaries of new filings.

Set up AI Radar — Free

Free account · 2 AI queries/day